Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02088853
Other study ID # BUTTER
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date December 2014

Study information

Verified date March 2019
Source Göteborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Human beings are 'omnivores' meaning that all principal components of food (i.e. the macronutrients: carbohydrates, fat, proteins) can be assimilated by the gastrointestinal tract. When the gut mucosa is exposed to dietary changes it adjusts its functional behaviour. For example, a fatty diet demands certain digestive mechanisms, whereas others are needed to take care of a carbohydrate rich diet. Such dietary induced changes in appearance and functionality of the small intestinal mucosa have been described in animals but only little is known about it in man. The present project aims at elucidating in man if a 2 weeks diet dominated by either fat or carbohydrates, but with similar energy content, is associated with changes in the small intestinal mucosal appearance and metabolic signalling capacity.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: healthy volunteer not taking prescribed medications BMI =25 kg/m2 Exclusion Criteria: BMI =26 kg/m2 smoker previous or current gastrointestinal disease significant abdominal surgery pregnancy/breast feeding drug intolerance of importance (particularly opiates and midazolam used during endoscopy) history of drug addiction

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
high fat diet (hfd)
Sixty % of the energy content is based on fat.
high carb diet
Sixty % of the energy content is based on carbohydrates.

Locations

Country Name City State
Sweden Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital Gothenburg

Sponsors (2)

Lead Sponsor Collaborator
Göteborg University Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mucosal surface enlargement factor The enlargement of the luminal surface area due to the villi structure is a morphometric factor defined as the total area of the mucosal surface in relation to the relatively flat area of the muscular is mucosae. Appearance after 2 weeks of diet
Secondary Epithelial electrical current in-vitro Mucosal biopsies are mounted in min Ussing chambers. Ion-transporting capacity via SGLT-1 transported is reflected when switching from glucose-free to glucose-containing luminal solution, selectivity of transporter is confirmed by addition of phloridzin. The condition after 2 weeks diet
Secondary Mucosal electrical resistance in vitro Mucosal biopsies are mounted in min Ussing chambers. Electrical resistance reflecting paracellular permeability is assessed when switching from glucose-free to glucose-containing luminal solution. The condition after 2 weeks diet
Secondary Glycemic control following a test meal Blood concentrations of glucose and insulin are assessed over 2 hours following a mixed test meal. The condition after 2 weeks diet
See also
  Status Clinical Trial Phase
Completed NCT02086253 - Role of Endothelin-1 in Flow-mediated Dilatation N/A